US › Healthcare

Shattuck Labs Inc (STTK)

US · Healthcare · Biotechnology

$7.92+8.64%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$0
Revenue YoY
-100.0%
Net profit
$-14.8M
Profit YoY
-7.8%
EPS
$-0.13
EPS estimate
$-0.13

EPS came in at -0.13 against a street estimate of -0.13 — a beat of 0.0%.

Key statistics

Market cap
$696.3M
Forward P/E
0.0
P/B
7.04
Book value
$1.27
EPS (TTM)
$-0.56
52-week high
$8.33
52-week low
$0.71
50-day MA
$6.06
200-day MA
$4.81
Beta
1.11

Analyst view

Analysts rate Shattuck Labs Inc a buy (2 buy, 3 hold, 0 sell out of 5) with an average price target of $14.38.

Shareholding

Insiders
4.53%
Institutions
60.06%

Largest institutional holders

FundStake
T. Rowe Price Investment Management,Inc.10.33%
Orbimed Advisors, LLC6.60%
Redmile Group, LLC5.80%
Prosight Management, LP5.24%
Adage Capital Partners Gp LLC4.86%
NEXTBio Capital Management LP3.30%
Vanguard Group Inc2.49%
Vanguard Capital Management, LLC2.38%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Shattuck Labs Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.